semaglutide nausea class action in louisiana vomiting lawsuit Filed Against Ozempic & Wegovy Makers louisiana semaglutide vomiting law firm – glp-1 gastroparesis lawsuit in louisiana

Leeson-Payne, A

& Habener, J

FDA approvals: what each drug is officially indicated for Sources: FDA prescribing information for Wegovy (2025), Mounjaro (2026), Zepbound (2025)

The Food and Drug Administration (FDA) reports that 5% of semaglutide users suffer from constipation

Shima Hadidchi MD Family Practice, we closely monitor all patients using these medications to ensure safety and effectiveness

compounding pharmacies Ongoing Support : Stay connected with unlimited virtual provider visits throughout your journeyall included in your $219/month flat rate Track Progress : Work with our team to monitor your results, adjust your dose as needed, and optimize your outcomes The Bottom Line Both semaglutide and tirzepatide represent significant advances in medical weight management